A comparison of the disease-modifying and cytokine-regulating activities of tenidap, piroxicam and cyclosporin-A using the adjuvant-induced model of arthritis in rats

Inflammopharmacology

Volumn 6, Issue 3, 1998, Pages 193-202

  Haynes, D R ^a   Hutchens, M J ^a   Whitehouse, M W ^a   Vernon Roberts, B ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Arthritis; Cyclosporin; Cytokines; Piroxicam; Tenidap

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; TENIDAP; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; LYMPH NODE CELL; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM MACROPHAGE; POLYARTHRITIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

EID: 0031755605     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-998-0019-z     Document Type: Article

References (21)

1. 1. PG Conaghan P Brooks 1993 Disease modifying anti-rheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and d-penicillamine Curr Opin Rheumatol. 5 276 81 8099805 1:STN:280:DyaK3s3ptV2muw%3D%3D 10.1097/00002281-199305030-00003 Conaghan PG, Brooks P. Disease modifying anti-rheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and d-penicillamine. Curr Opin Rheumatol. 1993;5:276–81.
2. 2. J Sany 1990 Immunological treatment of rheumatoid arthritis Clin Exp Rheumatol. 8 5 81 8 2245532 Sany J. Immunological treatment of rheumatoid arthritis. Clin Exp Rheumatol. 1990;8(5):81–8.
3. 3. P Larsson R Holmdahl L Denker L Klareskog 1985 In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats Immunology 56 383 91 2934315 1:STN:280:DyaL28%2Fotl2ltg%3D%3D Larsson P, Holmdahl R, Denker L, Klareskog L. In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology. 1985;56:383–91.
4. 4. DJ Whitehouse MW Whitehouse CM Pearson 1969 Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes Nature 224 1322 3 5359301 10.1038/2241322a0 1:STN:280:DyaE3c%2FmtVGgtA%3D%3D Whitehouse DJ, Whitehouse MW, Pearson CM. Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes. Nature. 1969;224:1322–3.
5. 5. IR Cohen J Holoshitz W Eden Van A Frenkel 1985 T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis Arthritis Rheum. 28 841 5 3875349 10.1002/art.1780280802 1:STN:280:DyaL2M3nvFKjsg%3D%3D Cohen IR, Holoshitz J, Van Eden W, Frenkel A. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum. 1985;28:841–5.
6. 6. DR Haynes SJ Gadd MW Whitehouse G Mayrhofer B Vernon-Roberts 1996 Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: The regulation of lymph node cell populations and cytokine production Inflamm Res. 45 159 65 8741004 10.1007/BF02285155 1:CAS:528:DyaK28XislCisbs%3D Haynes DR, Gadd SJ, Whitehouse MW, Mayrhofer G, Vernon-Roberts B. Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: The regulation of lymph node cell populations and cytokine production. Inflamm Res. 1996;45:159–65.
7. 7. JD Sipe LM Bartle LD Loose 1992 Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response J Immunol. 148 480 4 1729367 1:CAS:528:DyaK38XpvFSgsg%3D%3D Sipe JD, Bartle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol. 1992;148:480–4.
8. 8. RG Dolhain P Kuiper de CL Verweij 1995 Tenidap, but not non-steroidal anti-inflammatory drugs, inhibits T cell proliferation and cytokine induction Scand J Immunol. 42 686 93 8552993 10.1111/j.1365-3083.1995.tb03712.x 1:CAS:528:DyaK28XhtFWnsrg%3D Dolhain RG, de Kuiper P, Verweij CL, et al. Tenidap, but not non-steroidal anti-inflammatory drugs, inhibits T cell proliferation and cytokine induction. Scand J Immunol. 1995;42:686–93.
9. 9. MW Whitehouse KD Rainsford RM Taylor B Vernon-Roberts 1990 Zinc monoglycerolate: A slow release source of zinc with anti-arthritic activity in rats Agents Actions 31 47 58 2285022 10.1007/BF02003221 1:CAS:528:DyaK3cXmtFOqtbY%3D Whitehouse MW, Rainsford KD, Taylor RM, Vernon-Roberts B. Zinc monoglycerolate: A slow release source of zinc with anti-arthritic activity in rats. Agents Actions. 1990;31:47–58.
10. 10. DR Haynes IR Garrett MW Whitehouse B Vernon-Roberts 1988 Do gold drugs inhibit interleukin-1? Evidence for an in vitro lymphocyte activating factor assay J. Rheumatol. 15 775 8 3139878 1:CAS:528:DyaL1cXktlWktbs%3D Haynes DR, Garrett IR, Whitehouse MW, Vernon-Roberts, B. Do gold drugs inhibit interleukin-1? Evidence for an in vitro lymphocyte activating factor assay. J. Rheumatol. 1988;15:775–8.
11. 11. DR Haynes MW Whitehouse B Vernon-Roberts 1992 The prostaglandin analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E 1, E 2 and E 3 Immunology 76 251 7 1321792 1:CAS:528:DyaK38Xks1elt70%3D Haynes DR, Whitehouse MW, Vernon-Roberts B. The prostaglandin analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E 1, E 2 and E 3. Immunology. 1992;76:251–7.
12. 12. JJ Dixey FH Noormohamed AF Lant DA Brewerton 1988 Effect of maximal hydration on the renal responses to pretreatment with nonsteroidal anti-inflammatory drugs and probenecid in man Br J Clin Pharmacol. 25 614 17 3408640 1:CAS:528:DyaL1cXktlWksLg%3D Dixey JJ, Noormohamed FH, Lant AF, Brewerton DA. Effect of maximal hydration on the renal responses to pretreatment with nonsteroidal anti-inflammatory drugs and probenecid in man. Br J Clin Pharmacol. 1988;25:614–17.
13. 13. I Matsushita H Matsuno KM Kadowaki C Okada H Tsuji 1995 Immunomodulating effects of the new anti-rheumatic drug tenidap on collagen-induced arthritis Int J Immunopharmacol. 17 213 19 7558516 10.1016/0192-0561(95)00004-L 1:CAS:528:DyaK2MXls1amsLs%3D Matsushita I, Matsuno H, Kadowaki KM, Okada C, Tsuji H. Immunomodulating effects of the new anti-rheumatic drug tenidap on collagen-induced arthritis. Int J Immunopharmacol. 1995;17:213–19.
14. 14. WD Blackburn HM Prupas JC Silverfield 1995 Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone Arthritis Rheum. 38 1447 56 7575694 10.1002/art.1780381011 1:CAS:528:DyaK2MXpsl2ms7s%3D Blackburn WD Jr, Prupas HM, Silverfield JC et al. Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone. Arthritis Rheum. 1995;38:1447–56.
15. 15. G Wylie T Appelboom W Bolten 1995 A comparative study of tenidap, a cytokine-modulating antirheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial Br J Rheumatol. 34 554 63 7543348 10.1093/rheumatology/34.6.554 1:STN:280:DyaK2MzmtVChsg%3D%3D Wylie G, Appelboom T, Bolten W et al. A comparative study of tenidap, a cytokine-modulating antirheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. Br J Rheumatol. 1995;34:554–63.
16. 16. PA McNiff RE Laliberte L Svensson CJ Pazoles CA Gabel 1995 Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent Cytokine 7 196 208 7780040 10.1006/cyto.1995.1027 1:CAS:528:DyaK2MXksVGmtbc%3D McNiff PA, Laliberte RE, Svensson L, Pazoles CJ, Gabel CA. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. Cytokine. 1995;7:196–208.
17. 17. ED Rosenstein J Kunicka N Kramer G Goldstein 1994 Modification of cytokine production by piroxicam J. Rheumatol. 21 901 4 8064732 1:CAS:528:DyaK2cXlsVymtLg%3D Rosenstein ED, Kunicka J, Kramer N, Goldstein G. Modification of cytokine production by piroxicam. J. Rheumatol. 1994;21:901–4.
18. 18. AK Bahl MM Dale FC Foreman 1994 The effect of non-steroidal anti-inflammatory drugs on the accumulation and release of interleukin-1-like activity by peritoneal macrophages from the mouse Br J Pharmacol. 113 809 14 7858871 1:CAS:528:DyaK2cXmvFahtbk%3D Bahl AK, Dale MM, Foreman FC. The effect of non-steroidal anti-inflammatory drugs on the accumulation and release of interleukin-1-like activity by peritoneal macrophages from the mouse. Br J Pharmacol. 1994;113:809–14.
19. 19. DR Haynes PF Wright MW Whitehouse B Vernon-Roberts 1990 The cyclooxygenase inhibitor, piroxicam, enhances cytokine-induced lymphocyte proliferation Immunol Cell Biol. 68 225 30 2123471 10.1038/icb.1990.31 1:CAS:528:DyaK3MXit1Sqtr0%3D Haynes DR, Wright PF, Whitehouse MW, Vernon-Roberts B. The cyclooxygenase inhibitor, piroxicam, enhances cytokine-induced lymphocyte proliferation. Immunol Cell Biol. 1990;68:225–30.
20. 20. IG Otterness ML Bliven JD Eskra M Reinke DC Hanson 1988 The pharmacologic regulation of interleukin-1 production: the role of prostaglandins Cell Immunol. 114 385 97 2968844 10.1016/0008-8749(88)90330-9 1:CAS:528:DyaL1cXkslWktL0%3D Otterness IG, Bliven ML, Eskra JD, Reinke M, Hanson DC. The pharmacologic regulation of interleukin-1 production: the role of prostaglandins. Cell Immunol. 1988;114:385–97.
21. 21. RG Dolhain P Kuiper de CL Verweij 1995 Tenidap, but not non-steroidal anti-inflammatory drugs, inhibits T cell proliferation and cytokine induction Scand J Immunol. 42 686 93 8552993 10.1111/j.1365-3083.1995.tb03712.x 1:CAS:528:DyaK28XhtFWnsrg%3D Dolhain RG, de Kuiper P, Verweij CL et al. Tenidap, but not non-steroidal anti-inflammatory drugs, inhibits T cell proliferation and cytokine induction. Scand J Immunol. 1995;42:686–93.